Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context: LEADER Trial.
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical/endoscopic/histological disease activity in patients with inflammatory bowel disease (IBD) in Europe.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:
• ≥18 years
• Patient with confirmed diagnosis of IBD
• Patient with planned endoscopy (ileocolonoscopy for Crohn's disease (CD)/ulcerative colitis (UC) or sigmoidoscopy for UC) for the assessment of endoscopic disease activity according to routine practice
• willing to provide informed consent
Locations
Other Locations
Belgium
Imelda General Hospital
RECRUITING
Bonheiden
Contact Information
Primary
Peter Bossuyt
peter.bossuyt@imelda.be
MD PhD
Time Frame
Start Date: 2026-05-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 100
Treatments
patient with IBD
patient with Crohn or ulcerative colitis
Related Therapeutic Areas
Sponsors
Leads: Imelda GI Clinical Research Center